Jiří Slabý

582 total citations · 1 hit paper
22 papers, 415 citations indexed

About

Jiří Slabý is a scholar working on Molecular Biology, Biomedical Engineering and Hematology. According to data from OpenAlex, Jiří Slabý has authored 22 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Biomedical Engineering and 5 papers in Hematology. Recurrent topics in Jiří Slabý's work include Plasmonic and Surface Plasmon Research (7 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Gold and Silver Nanoparticles Synthesis and Applications (5 papers). Jiří Slabý is often cited by papers focused on Plasmonic and Surface Plasmon Research (7 papers), Advanced biosensing and bioanalysis techniques (5 papers) and Gold and Silver Nanoparticles Synthesis and Applications (5 papers). Jiří Slabý collaborates with scholars based in Czechia, United States and Canada. Jiří Slabý's co-authors include Jiřı́ Homola, Markéta Bocková, Tomáš Špringer, Barbora Špačková, N. Scott Lynn, Hana Šípová, Ryan Shanley, Celalettin Üstün, Jan Vydra and Jo‐Anne H. Young and has published in prestigious journals such as Blood, The Journal of Physical Chemistry C and Nanoscale.

In The Last Decade

Jiří Slabý

20 papers receiving 406 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Surface plasmon resonance biosensors and their medical applications

2025 25 citations Tomáš Špringer, Markéta Bocková et al. Biosensors and Bioelectronics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jiří Slabý Czechia	11	199	148	79	66	52	22	415
B. Fischer Germany	16	291 1.5×	129 0.9×	87 1.1×	230 3.5×	32 0.6×	53	888
Chun-Ting Yang Taiwan	9	187 0.9×	67 0.5×	50 0.6×	38 0.6×	11 0.2×	24	385
Shijie Cai China	14	187 0.9×	248 1.7×	121 1.5×	282 4.3×	70 1.3×	39	883
Junjie Lu China	12	82 0.4×	203 1.4×	41 0.5×	108 1.6×	45 0.9×	38	552
Victor Ong Singapore	11	91 0.5×	99 0.7×	16 0.2×	200 3.0×	23 0.4×	34	597
Sara Nizzero United States	12	181 0.9×	124 0.8×	59 0.7×	23 0.3×	16 0.3×	21	467
Hye Kyung Chang South Korea	16	64 0.3×	152 1.0×	11 0.1×	152 2.3×	57 1.1×	43	741
Eric Wong United States	12	117 0.6×	165 1.1×	59 0.7×	95 1.4×	83 1.6×	32	617
Wenen Liu China	11	70 0.4×	74 0.5×	36 0.5×	42 0.6×	73 1.4×	23	344
Cheng Wei Tony Yang Canada	13	192 1.0×	157 1.1×	13 0.2×	94 1.4×	41 0.8×	28	588

Countries citing papers authored by Jiří Slabý

Since Specialization

Citations

This map shows the geographic impact of Jiří Slabý's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiří Slabý with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiří Slabý more than expected).

Fields of papers citing papers by Jiří Slabý

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiří Slabý. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiří Slabý. The network helps show where Jiří Slabý may publish in the future.

Co-authorship network of co-authors of Jiří Slabý

This figure shows the co-authorship network connecting the top 25 collaborators of Jiří Slabý. A scholar is included among the top collaborators of Jiří Slabý based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiří Slabý. Jiří Slabý is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Špringer, Tomáš, et al.. (2025). Surface plasmon resonance biosensors and their medical applications. Biosensors and Bioelectronics. 278. 117308–117308. 25 indexed citations breakdown →

Halahovets, Yuriy, Jiří Slabý, Jiřı́ Homola, et al.. (2022). Grafting density and antifouling properties of poly[N-(2-hydroxypropyl) methacrylamide] brushes prepared by “grafting to” and “grafting from”. Polymer Chemistry. 13(25). 3815–3826. 33 indexed citations

Slabý, Jiří & Jiřı́ Homola. (2022). Performance of label-free optical biosensors: What is figure of merit (not) telling us?. Biosensors and Bioelectronics. 212. 114426–114426. 10 indexed citations

Slabý, Jiří, Markéta Bocková, & Jiřı́ Homola. (2021). Plasmonic biosensor based on a gold nanostripe array for detection of microRNA related to myelodysplastic syndromes. Sensors and Actuators B Chemical. 347. 130629–130629. 17 indexed citations

Fossati, Stefan, Priyamvada Venugopalan, Jiří Slabý, et al.. (2020). Actuated plasmonic nanohole arrays for sensing and optical spectroscopy applications. Nanoscale. 12(17). 9756–9768. 29 indexed citations

Lynn, N. Scott, Tomáš Špringer, Jiří Slabý, et al.. (2019). Analyte transport to micro- and nano-plasmonic structures. Lab on a Chip. 19(24). 4117–4127. 7 indexed citations

Bocková, Markéta, Jiří Slabý, Tomáš Špringer, & Jiřı́ Homola. (2019). Advances in Surface Plasmon Resonance Imaging and Microscopy and Their Biological Applications. Annual Review of Analytical Chemistry. 12(1). 151–176. 93 indexed citations

Špačková, Barbora, N. Scott Lynn, Jiří Slabý, Hana Šípová, & Jiřı́ Homola. (2018). A Route to Superior Performance of a Nanoplasmonic Biosensor: Consideration of Both Photonic and Mass Transport Aspects. ACS Photonics. 5(3). 1019–1025. 48 indexed citations

Maity, Ranjan, Paola Neri, Li Ren, et al.. (2014). Cereblon (CRBN) Splice Isoform Lacking Exon 10 Attenuates Lenalidomide-Mediated Degradation of Aiolos and Is Upregulated in Immunomodulatory Drugs (IMiDs) Resistant Myeloma (MM) Patients. Blood. 124(21). 639–639. 3 indexed citations

10.

Neri, Paola, et al.. (2013). XPO1 Inhibition Disrupts Ribosomal Subunits Assembly and Induces Multiple Myeloma (MM) Cell Death. Blood. 122(21). 3165–3165. 5 indexed citations

11.

Üstün, Celalettin, Jiří Slabý, Ryan Shanley, et al.. (2012). Human Parainfluenza Virus Infection after Hematopoietic Stem Cell Transplantation: Risk Factors, Management, Mortality, and Changes over Time. Biology of Blood and Marrow Transplantation. 18(10). 1580–1588. 49 indexed citations

12.

Klimowicz, Alexander C., Paola Neri, Andrew Belch, et al.. (2012). High Cereblon Protein Expression Correlates with Improved Response and Survival in Myeloma Patients Treated with Lenalidomide. Blood. 120(21). 931–931. 9 indexed citations

13.

Neri, Paola, Peter Duggan, Kathy Gratton, et al.. (2012). Phase I Study of the PARP1-2 Inhibitor Veliparib in Combination with Bortezomib in Patients with Relapsed or Refractory Multiple Myeloma. Blood. 120(21). 1862–1862. 3 indexed citations

14.

Slabý, Jiří, Paola Neri, Kathy Gratton, et al.. (2012). Lenalidomide Suppresses 5′-Cap-Independent C-MYC Translation in Multiple Myeloma Cells. Blood. 120(21). 3943–3943. 1 indexed citations

15.

Phelan, Paul J., Patrick O’Kelly, John Holian, et al.. (2010). Warfarin use in hemodialysis patients: what is the risk?. Clinical Nephrology. 75(3). 204–211. 35 indexed citations

16.

Connaughton, Dervla M., Paul J. Phelan, Marwan Ma’ayeh, et al.. (2010). The impact of peritransplant warfarin use on renal transplant outcome. Journal of Nephrology. 23(5). 587–592. 8 indexed citations

17.

Faber, Edgar, Robert Pytlík, Jiří Slabý, et al.. (2006). Individually determined dosing of filgrastim after autologous peripheral stem cell transplantation in patients with malignant lymphoma – results of a prospective multicentre controlled trial. European Journal Of Haematology. 77(6). 493–500. 12 indexed citations

18.

Slabý, Jiří, et al.. (2004). Comparison of various substrate technologies under steady state and transient conditions. 648–654. 2 indexed citations

19.

Slabý, Jiří, et al.. (2002). [Predictive features of positron emission tomography after two cycles of induction therapy in malignant lymphoma].. PubMed. 141(10). 312–5. 4 indexed citations

20.

Merta, M, et al.. (1995). [Renal impairment in monoclonal gammapathies. Clinical study].. PubMed. 134(15). 478–81.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact